4.19
price down icon12.89%   -0.62
pre-market  Pre-mercato:  4.07   -0.12   -2.86%
loading
Precedente Chiudi:
$4.81
Aprire:
$4.74
Volume 24 ore:
115.66K
Relative Volume:
2.33
Capitalizzazione di mercato:
$23.57M
Reddito:
$257.00K
Utile/perdita netta:
$-3.07M
Rapporto P/E:
-4.398
EPS:
-0.9527
Flusso di cassa netto:
$-1.40M
1 W Prestazione:
-14.75%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$4.03
$4.80
Intervallo di 1 settimana:
Value
$4.00
$5.13
Portata 52W:
Value
$4.00
$6.20

Optimi Health Corp Stock (OPTH) Company Profile

Name
Nome
Optimi Health Corp
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
9
Name
Cinguettio
Name
Prossima data di guadagno
null
Name
Ultimi documenti SEC
Name
OPTH's Discussions on Twitter

Compare OPTH vs TAK, HLN, TEVA, ZTS, UTHR

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
OPTH icon
OPTH
Optimi Health Corp
4.19 27.06M 257.00K -3.07M -1.40M -0.9527
TAK icon
TAK
Takeda Pharmaceutical Co Adr
15.66 49.83B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
9.09 40.04B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
32.91 39.23B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
79.33 33.52B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
548.27 23.33B 3.17B 1.29B 1.01B 27.09

Optimi Health Corp Borsa (OPTH) Ultime notizie

pulisher
Jun 15, 2026

Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat

Jun 15, 2026
pulisher
Jun 12, 2026

SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits

Jun 12, 2026
pulisher
Jun 12, 2026

Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance

Jun 12, 2026
pulisher
Jun 10, 2026

Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com Australia

Jun 10, 2026
pulisher
Jun 10, 2026

Optimi Health ships psilocybin to UK for clinical trial - Investing.com

Jun 10, 2026
pulisher
Jun 10, 2026

Optimi Health Completes First Psilocybin Export to UK for Planned Phase 2 Trial - citybuzz -

Jun 10, 2026
pulisher
Jun 10, 2026

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - PR Newswire

Jun 10, 2026
pulisher
Jun 10, 2026

Optimi Health exports psilocybin to UK for clinical trial By Investing.com - Investing.com South Africa

Jun 10, 2026
pulisher
Jun 10, 2026

Optimi Health exports psilocybin to UK for clinical trial - Investing.com UK

Jun 10, 2026
pulisher
Jun 10, 2026

Optimi Health Completes First Export of Psilocybin to UK - marketscreener.com

Jun 10, 2026
pulisher
Jun 10, 2026

Optimi Health Corp. Completes First Export of Psilocybin to the UK for Phase 2 Clinical Trial - Quiver Quantitative

Jun 10, 2026
pulisher
Jun 10, 2026

OPTH SEC FilingsOptimi Health 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 10, 2026
pulisher
Jun 09, 2026

Optimi Health Corp. (OPTH) Price Book Value - Zacks Investment Research

Jun 09, 2026
pulisher
Jun 09, 2026

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development - The Malaysian Reserve

Jun 09, 2026
pulisher
Jun 08, 2026

GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Weekly Voice

Jun 08, 2026
pulisher
Jun 08, 2026

Optimi Health stock surges on ibogaine supply deal By Investing.com - Investing.com Australia

Jun 08, 2026
pulisher
Jun 08, 2026

Optimi Health stock surges on ibogaine supply deal - Investing.com

Jun 08, 2026
pulisher
Jun 08, 2026

US order prioritizes ibogaine; Optimi Health builds GMP supply in Canada - Stock Titan

Jun 08, 2026
pulisher
Jun 05, 2026

OPTH Stock Chart | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill

Jun 05, 2026
pulisher
Jun 05, 2026

OPTH Technical Analysis | Trend, Signals & Chart Patterns | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill

Jun 05, 2026
pulisher
Jun 05, 2026

Optimi Health Corp.Common Shares (Nasdaq:OPTH) Stock Quote - FinancialContent

Jun 05, 2026
pulisher
Jun 04, 2026

Optimi Health (OPTH) Stock Forecast and Price Target 2026 - MarketBeat

Jun 04, 2026
pulisher
Jun 02, 2026

Optimi Health completes GMP production of psilocybin capsules By Investing.com - Investing.com Canada

Jun 02, 2026
pulisher
Jun 02, 2026

Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - PR Newswire Canada

Jun 02, 2026
pulisher
Jun 02, 2026

Optimi Health completes GMP production of psilocybin capsules - Investing.com UK

Jun 02, 2026
pulisher
Jun 02, 2026

OPTH | Optimi Health Corp. Common Institutional Ownership - Quiver Quantitative

Jun 02, 2026
pulisher
Jun 02, 2026

OPTH Stock Price, Quote & Chart | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill

Jun 02, 2026
pulisher
Jun 02, 2026

OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill

Jun 02, 2026
pulisher
Jun 02, 2026

Psilocybin pills prescribed for hard-to-treat depression in Australia - Stock Titan

Jun 02, 2026
pulisher
May 30, 2026

Price to book ratio of Optimi Health Corp. – DUS:8BN0 - TradingView

May 30, 2026
pulisher
May 29, 2026

Optimi Health (OPTH) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update - NewMediaWire

May 29, 2026
pulisher
May 29, 2026

What is the current Price Target and Forecast for Optimi Health Corp. (OPTH) - Zacks Investment Research

May 29, 2026

Optimi Health Corp Azioni (OPTH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
RGC RGC
$16.73
price down icon 2.11%
RDY RDY
$13.30
price down icon 0.23%
$24.23
price down icon 0.25%
$156.42
price down icon 1.94%
$16.04
price down icon 1.72%
$548.27
price down icon 0.24%
Capitalizzazione:     |  Volume (24 ore):